Zacks.com users have recently been watching P&G (PG) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Procter & Gamble remains a 'Hold' as shares trade slightly above intrinsic value despite a wide economic moat and solid fundamentals. Procter & Gamble's Q1/26 saw 3% revenue growth and 21% EPS growth, but management guides for low-to-mid single-digit growth ahead. Valuation multiples—20.5x earnings and 23x FCF—remain elevated relative to growth prospects, with intrinsic value estimated at $122.63.
Shares of The Procter & Gamble Company PG hit a new 52-week low of $137.62 yesterday, before rising a notch higher to close at $138.04. The stock has been volatile in recent months, weighed down by soft category demand, intensifying promotional activity and a challenging macroeconomic environment across key markets.
Procter & Gamble is undervalued, trading at 20x earnings with a 3% yield and strong dividend safety, making it a buy. PG's focused brand portfolio, sector-leading margins, and 40 consecutive quarters of organic sales growth reinforce its market leadership and resilience. Cost reductions, supply chain restructuring, and ongoing innovation underpin margin expansion and defend PG's wide moat.
In the most recent trading session, Procter & Gamble (PG) closed at $140.37, indicating a -1% shift from the previous trading day.
PG posts solid Q1 earnings via pricing and productivity, but weak volume in North America raises doubts about sustaining top-line momentum.
Procter & Gamble (PG) closed at $141.79 in the latest trading session, marking a -1.06% move from the prior day.
Procter & Gamble leans on Focus Markets for growth, with China improving, Europe mixed results and Baby Care innovation aimed at offsetting softer demand.
P&G (PG) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
PG's insight-led innovation and productivity gains are supporting margins and reinforcing brand leadership in FY26.
Procter & Gamble (NYSE: PG) stock has recently caught attention after Jim Cramer made a positive case for the stock. Both PG and its rival Colgate-Palmolive (CL) are down approximately 12% year-to-date, lagging behind the broader S&P 500, which has risen by 16%.
P&G (PG) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.